Return On Assets in % of Nascent Biotech Inc. from Q3 2015 to Q2 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nascent Biotech Inc. quarterly and annual Return On Assets history and change rate from Q3 2015 to Q2 2024.
  • Nascent Biotech Inc. Return On Assets for the quarter ending 30 Jun 2024 was -313%, a 19.6% increase year-over-year.
  • Nascent Biotech Inc. annual Return On Assets for 2023 was -379%, a 58.1% increase from 2022.
  • Nascent Biotech Inc. annual Return On Assets for 2022 was -905%, a 344% decline from 2021.
  • Nascent Biotech Inc. annual Return On Assets for 2021 was -204%, a 99.2% increase from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Nascent Biotech Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q2 2024 -313% +76% +20% 01 Apr 2024 30 Jun 2024
Q1 2024 -361% +147% +29% 01 Jan 2024 31 Mar 2024
Q4 2023 -415% +108% +21% 01 Oct 2023 31 Dec 2023
Q3 2023 -561% -337% -151% 01 Jul 2023 30 Sep 2023
Q2 2023 -389% +72% +16% 01 Apr 2023 30 Jun 2023
Q1 2023 -508% -356% -234% 01 Jan 2023 31 Mar 2023
Q4 2022 -523% -591% -872% 01 Oct 2022 31 Dec 2022
Q3 2022 -224% +107% +32% 01 Jul 2022 30 Sep 2022
Q2 2022 -461% -59% -15% 01 Apr 2022 30 Jun 2022
Q1 2022 -152% +263% +63% 01 Jan 2022 31 Mar 2022
Q4 2021 68% +10,009% 01 Oct 2021 31 Dec 2021
Q3 2021 -331% +15,035% +98% 01 Jul 2021 30 Sep 2021
Q2 2021 -402% +143,451% +100% 01 Apr 2021 30 Jun 2021
Q1 2021 -415% +100,407% +100% 01 Jan 2021 31 Mar 2021
Q4 2020 -9,942% -6,305% -173% 01 Oct 2020 31 Dec 2020
Q3 2020 -15,366% -13,417% -688% 01 Jul 2020 30 Sep 2020
Q2 2020 -143,853% -142,480% -10,374% 01 Apr 2020 30 Jun 2020
Q1 2020 -100,822% -99,433% -7,156% 01 Jan 2020 31 Mar 2020
Q4 2019 -3,636% -1,702% -88% 01 Oct 2019 31 Dec 2019
Q3 2019 -1,949% -1,155% -146% 01 Jul 2019 30 Sep 2019
Q2 2019 -1,373% -956% -229% 01 Apr 2019 30 Jun 2019
Q1 2019 -1,389% -1,107% -391% 01 Jan 2019 31 Mar 2019
Q4 2018 -1,934% -1,742% -907% 01 Oct 2018 31 Dec 2018
Q3 2018 -794% -605% -320% 01 Jul 2018 30 Sep 2018
Q2 2018 -417% -433% -2,650% 01 Apr 2018 30 Jun 2018
Q1 2018 -283% -396% -350% 01 Jan 2018 31 Mar 2018
Q4 2017 -192% -268% -354% 01 Oct 2017 31 Dec 2017
Q3 2017 -189% -286% -295% 01 Jul 2017 30 Sep 2017
Q2 2017 16% +284% 01 Apr 2017 30 Jun 2017
Q1 2017 113% +523% 01 Jan 2017 31 Mar 2017
Q4 2016 76% +560% 01 Oct 2016 31 Dec 2016
Q3 2016 97% +707% 01 Jul 2016 30 Sep 2016
Q2 2016 -268% 01 Apr 2016 30 Jun 2016
Q1 2016 -410% 01 Jan 2016 31 Mar 2016
Q4 2015 -484% 01 Oct 2015 31 Dec 2015
Q3 2015 -611% 01 Jul 2015 30 Sep 2015

Nascent Biotech Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2023 -379% +526% +58% 01 Apr 2023 31 Mar 2024
2022 -905% -701% -344% 01 Apr 2022 31 Mar 2023
2021 -204% +23,938% +99% 01 Apr 2021 31 Mar 2022
2020 -24,141% -20,077% -494% 01 Apr 2020 31 Mar 2021
2019 -4,064% -3,890% -2,232% 01 Apr 2019 31 Mar 2020
2018 -174% +47% +21% 01 Apr 2018 31 Mar 2019
2017 -221% -333% -297% 01 Apr 2017 31 Mar 2018
2016 112% 01 Apr 2016 31 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.